Eric A Young - Net Worth and Insider Trading
Eric A Young Net Worth
The estimated net worth of Eric A Young is at least $2.3 Billion dollars as of 2024-09-21. Eric A Young is the 10% Owner of DexCom Inc and owns about 32,650,160 shares of DexCom Inc (DXCM) stock worth over $2.3 Billion. Details can be seen in Eric A Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric A Young has not made any transactions after 2005-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric A Young
Eric A Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric A Young owns 4 companies in total, including Amicus Therapeutics Inc (FOLD) , EPIRUS Biopharmaceuticals Inc (EPRSQ) , and DexCom Inc (DXCM) among others .
Click here to see the complete history of Eric A Young’s form 4 insider trades.
Insider Ownership Summary of Eric A Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2007-05-30 | 10 percent owner |
| EPRSQ | EPIRUS Biopharmaceuticals Inc | 2005-11-15 | 10 percent owner |
| DXCM | DexCom Inc | 2005-11-10 | 10 percent owner |
 | | 2004-09-10 | director |
Eric A Young Latest Holdings Summary
Eric A Young currently owns a total of 1 stock. Eric A Young owns 32,650,160 shares of DexCom Inc (DXCM) as of November 10, 2005, with a value of $2.3 Billion.
Latest Holdings of Eric A Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DXCM | DexCom Inc | 2005-11-10 | 32,650,160 | 70.44 | 2,299,877,270 |
Holding Weightings of Eric A Young
Eric A Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric A Young has made a total of 0 transactions in DexCom Inc (DXCM) over the past 5 years. The most-recent trade in DexCom Inc is the sale of 16,848,000 shares on November 10, 2005, which brought Eric A Young around $14 Million.
Insider Trading History of Eric A Young
- 1
Eric A Young Trading Performance
Eric A Young Ownership Network
Eric A Young Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Eric A Young is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Eric A Young made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 351,367 shares made by John F Crowley , a net sale of 233,261 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .
In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 822,412 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 822,412 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Eric A Young Mailing Address
Above is the net worth, insider trading, and ownership report for Eric A Young. You might contact Eric A Young via mailing address: C/o Canaan Partners, 285 Riverside Avenue, Suite 250, Westford Ct 06880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
